Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

NCT00612716 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Leukemia
Lymphoma
Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: busulfan
DRUG: cyclophosphamide
BIOLOGICAL: Stem cell infusion
RADIATION: Total body irradiation

Sponsor

Masonic Cancer Center, University of Minnesota